Trial Condition(s):

Rosacea

Preferences & Treatment Satisfaction Drivers in Rosacea Patients

Bayer Identifier:

18575

ClinicalTrials.gov Identifier:

NCT02602470

EudraCT Number:

Not Available

Study Completed

Trial Purpose

To survey patients with rosacea about their rosacea treatment preferences as well as to assess potential drivers of rosacea treatment satisfaction.

Inclusion Criteria
-  Male or female patients of at least 18 years of age at index date
 -  At least one prescription for a topical rosacea treatments: Azelaic Acid Gel, Azelaic Acid Cream, Metronidazole Gel, Metronidazole Cream, Metronidazole Emulsion, Metronidazole Lotion, Brimonidine Tartrate Gel       
 -  At least one medical record with a diagnosis code for rosacea (ICD-9: 695.3)
 -  At least 6 months of data history prior to the index date
 -  Had at least one encounter at the Reliant Medical Group  within 3 months prior to 01 January 2015
Exclusion Criteria
-  None

Trial Summary

Enrollment Goal
206
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Finacea (Azelaic Acid, BAY39-6251)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Boston, United States

Status
Completed
 

Trial Design